Automated Sample Preparation and High-Throughput Cell Analysis in the Circulating Tumor Cells (CTC)
Author : Ash Hiwarkar | Published On : 29 Oct 2026
The global circulating tumor cells (CTC) market was valued at USD 14.31 billion in 2025 and is projected to grow from USD 15.77 billion in 2026 to USD 34.30 billion by 2034, registering a CAGR of 10.2%. North America held a 39.2% market share in 2025. Circulating tumor cells are cancer cells that detach from a primary tumor and enter the bloodstream. Their detection can help assess prognosis and support treatment decisions in certain cancers.
Market Drivers
Demand for Cancer Monitoring: CTC analysis can help clinicians assess disease progression and treatment response in selected cancers, supporting demand for specialized diagnostic technologies.
Advances in Liquid Biopsy Technologies: Improved cell-capture methods, microfluidic systems, and sensitive detection platforms support the analysis of rare tumor cells from blood samples.
Market Restraints
Low CTC Concentration in Blood: Circulating tumor cells can occur at very low levels, making their isolation and detection technically challenging.
Clinical Validation Requirements: Differences in test performance and clinical evidence can limit the use of CTC technologies across cancer types and treatment settings.
Market Opportunities
Personalized Cancer Treatment: CTC characterization can provide information about tumor biology and may support treatment selection and monitoring in specific clinical settings.
Advanced Cell-Capture Platforms: Nanotechnology, microfluidic devices, and automated laboratory systems offer opportunities to improve the recovery and analysis of rare tumor cells.
Market Segmentation
The circulating tumor cells market can be segmented by technology, application, specimen type, end user, and region. Key applications include cancer diagnosis support, prognosis assessment, treatment monitoring, and research, while end users include hospitals, diagnostic laboratories, and research institutions.
Key Players
Menarini Silicon Biosystems, Bio-Techne Corporation, QIAGEN N.V., Precision for Medicine, and Fluxion Biosciences.
Contact Us
Phone: U.S. +1 646 905 0080 | India +91 8087085354 | U.K. +44 203 695 0070
Related Link: https://straitsresearch.com/report/circulating-tumor-cells-market
